Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P

Journal of Virology

Volumn 77, Issue 18, 2003, Pages 9831-9844

  Haynes, Lia M ^a   Jones, Les P ^a   Barskey, Albert ^a   Anderson, Larry J ^a   Tripp, Ralph A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; CX3C CHEMOKINE; FORMALDEHYDE; SUBSTANCE P; T LYMPHOCYTE RECEPTOR BETA CHAIN; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; LOEFFLER PNEUMONIA; LOWER RESPIRATORY TRACT INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS INACTIVATION;

AMINO ACID MOTIFS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES; CHEMOKINES, CX3C; FEMALE; FORMALDEHYDE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PULMONARY EOSINOPHILIA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, CHEMOKINE; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; SUBSTANCE P; VACCINATION; VACCINES, INACTIVATED; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0141793845     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.18.9831-9844.2003     Document Type: Article

References (76)

1. Anonymous. 2002. Respiratory syncytial virus activity - United States, 2000-01 season. Morb. Mortal. Wkly. Rep. 51:26-28.
2. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644.
3. Borchers, M. T., T. Ansay, R. DeSalle, B. L. Daugherty, H. Shen, M. Metzger, N. A. Lee, and J. J. Lee. 2002. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J. Leukoc. Biol. 71:1033-1041.
4. Chakravorty, S. J., P. Cockwell, J. Girdlestone, C. J. Brooks, and C. O. Savage. 2002. Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin. Exp. Immunol. 129:150-159.
5. Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, and E. H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
6. Combadiere, C., J. Gao, H. L. Tiffany, and P. M. Murphy. 1998. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem. Biophys. Res. Commun. 253:728-732.
7. Couch, R. B., J. A. Englund, and E. Whimbey. 1997. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102:2-9.
8. Dichmann, S., Y. Herouy, D. Purlis, H. Rheinen, P. Gebicke-Harter, and J. Norgauer. 2001. Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm. Res. 50:529-533.
9. Domachowske, J. B., C. A. Bonville, J. L. Gao, P. M. Murphy, A. J. Easton, and H. F. Rosenberg. 2000. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J. Immunol. 165:2677-2682.
10. Drakes, M. L., A. F. Zahorchak, T. Takayama, L. Lu, and A. W. Thomson. 2000. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells. Transpl. Immunol. 8:17-29.
11. Dunzendorfer, S., C. Meierhofer, and C. J. Wiedermann. 1998. Signaling in neuropeptide-induced migration of human eosinophils. J. Leukoc. Biol. 64:828-834.
12. Durbin, J. E., T. R. Johnson, R. K. Durbin, S. E. Mertz, R. A. Morotti, R. S. Peebles, and B. S. Graham, 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944-2952.
13. Falsey, A. R. 1998. Respiratory syncytial virus infection in older persons. Vaccine 16:1775-1778.
14. Falsey, A. R., and E. E. Walsh. 2000. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13:371-384.
15. Fraticelli, P., M. Sironi, G. Bianchi, D. D'Ambrosio, C. Albanesi, A. Stoppacciaro, M. Chieppa, P. Allavena, L. Ruco, G. Girolomoni, F. Sinigaglia, A. Vecchi, and A. Mantovani. 2001. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 107:1173-1181.
16. Fujimoto, K., T. Imaizumi, H. Yoshida, S. Takanashi, K. Okumura, and K. Satoh. 2001. Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am. J. Respir. Cell. Mol. Biol. 25:233-238.
17. Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
18. Gabuzda, D., and J. Wang. 1999. Chemokine receptors and virus entry in the central nervous system. J. Neurovirol. 5:643-658.
19. Garland, A., J. Necheles, S. R. White, S. P. Neeley, A. R. Leff, S. S. Carson, L. E. Alger, K. McAllister, and J. Solway. 1997. Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. Am. J. Physiol. 273:L1096-L1102.
20. Glezen, W. P., S. B. Greenberg, R. L. Atmar, P. A. Piedra, and R. B. Couch. 2000. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283:499-505.
21. Graham, B. S. 1996. Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol. 4:290-293.
22. Graham, B. S. 1995. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am. J. Respir. Crit. Care Med. 152:S63-S66.
23. Graham, B. S., T. R. Johnson, and R. S. Peebles. 2000. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48:237-247.
24. Graham, B. S., J. A. Rutigliano, and T. R. Johnson. 2002. Respiratory syncytial virus immunobiology and pathogenesis. Virology 297:1-7.
25. Guo, J., M. Zhang, B. Wang, Z. Yuan, Z. Guo, T. Chen, Y. Yu, Z. Qin, and X. Cao. 2003. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. Int. J. Cancer 103:212-220.
26. Hall, C. B. 1999. Respiratory syncytial virus: a continuing culprit and conun-drum. J. Pediatr. 135:2-7.
27. Hancock, G. E., D. J. Speelman, K. Heers, E. Bortell, J. Smith, and C. Cosco. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70:7783-7791.
28. Harrison, J. K., Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R. K. McNamara, W. J. Streit, M. N. Salafranca, S. Adhikari, D. A. Thompson, P. Botti, K. B. Bacon, and L. Feng. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95:10896-10901.
29. Hatori, K., A. Nagai, R. Heisel, J. K. Ryu, and S. U. Kim. 2002. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69:418-426.
30. Haynes, L. M., J. Tonkin, L. J. Anderson, and R. A. Tripp. 2002. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection. J. Virol. 76:6873-6881.
31. Hesselgesser, J., and R. Horuk. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:13-26.
32. Hughes, P. M., M. S. Botham, S. Frentzel, A. Mir, and V. H. Perry. 2002. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-327.
33. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CRI, which mediates both leukocyte migration and adhesion. Cell 91:521-530.
34. Johnson, T. R., and B. S. Graham. 1999. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J. Virol. 73:8485-8495.
35. Johnson, T. R., J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham. 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72:2871-2880.
36. Joos, G. F., K. O. De Swert, and R. A. Pauwels. 2001. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur. J. Pharmacol. 429:239-250.
37. Joos, G. F., P. R. Germonpre, and R. A. Pauwels. 2000. Neural mechanisms in asthma. Clin. Exp. Allergy 30(Suppl. 1):60-65.
38. Kanazawa, N., T. Nakamura, K. Tashiro, M. Muramatsu, K. Morita, K. Yoneda, K. Inaba, S. Imamura, and T. Honjo, 1999. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol. 29:1925-1932.
39. Karron, R. A., D. A. Buonagurio, A. F. Georgiu, S. S. Whitehead, J. E. Adamus, M. L. Clements-Mann, D. O. Harris, V. B. Randolph, S. A. Udem, B. R. Murphy, and M. S. Sidhu. 1997. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94:13961-13966.
40. Kudlacz, E., C. Whitney, C. Andresenl, and M. Conklyn. 2002. Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils. Inflammation 26:111-119.
41. Lambrecht, B. N. 2001. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res. 2:133-138.
42. Levite, M. 2000. Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function. Ann. N.Y. Acad. Sci. 917:307-321.
43. Levite, M. 1998. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. USA 95:12544-12549.
44. Ludwig, A., T. Berkhout, K. Moores, P. Groot, and G. Chapman. 2002. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J. Immunol. 168:604-612.
45. Lukacs, N. W., T. J. Standiford, S. W. Chensue, R. G. Kunkel, R. M. Strieter and S. L. Kunkel. 1996. C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation. J. Leukoc. Biol. 60:573-578.
46. Meucci, O., A. Fatatis, A. A. Simen, and R. J. Miller. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97:8075-8080.
47. Oh, S. B., P. B. Tran, S. E. Gillard, R. W. Hurley, D. L. Hammond, and R. J. Miller. 2001. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 21:5027-5035.
48. Oliveira, S. H., S. Lira, A. C. Martinez, M. Wiekowski, L. Sullivan, and N. W. Lukacs. 2002. Increased responsiveness of murine eosinophils to MIP-1beta (CCLA) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J. Leukoc. Biol. 71:1019-1025.
49. Openshaw, P. J. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 17:187-201.
50. Openshaw, P. J. 2002. Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir. Res. 3:S15-S20.
51. Openshaw, P. J., F. J. Culley, and W. Olszewska. 2001. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 20(Suppl. 1):S27-S31.
52. Papadopoulos, E. J., C. Sassetti, H. Saeki, N. Yamada, T. Kawamura, D. J. Fitzhugh, M. A. Saraf, T. Schall, A. Blauvelt, S. D. Rosen, and S. T. Hwang. 1999. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur. J. Immunol. 29:2551-2559.
53. Penna, G., M. Vulcano, S. Sozzani, and L. Adorini. 2002. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 63:1164-1171.
54. Prince, G. A. 2001. An update on respiratory syncytial virus antiviral agents. Expert Opin. Investig. Drugs 10:297-308.
55. Rameshwar, P. 1997. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions. Clin. Immunol. Immunopathol. 85:129-133.
56. Rueda, P., B. Garcia-Barreno, and J. A. Melero. 1994. Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 198:653-662.
57. Sabroe, I., A. Hartnell, L. A. Jopling, S. Bel, P. D. Ponath, J. E. Pease, P. D. Collins, and T. J. Williams. 1999. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol. 162:2946-2955.
58. Schaffer, M., T. Beiter, H. D. Becker, and T. K. Hunt. 1998. Neuropeptides: mediators of inflammation and tissue repair? Arch. Surg. 133:1107-1116.
59. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, and L. J. Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440-1446.
60. Simoes, E. A. 1999. Respiratory syncytial virus infection. Lancet 354:847-852.
61. Sparer, T. E., S. Matthews, T. Hussell, A. J. Rae, B. Garcia-Barreno, J. A. Melero, and P. J. Openshaw. 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp Med. 187:1921-1926.
62. Staat, M. A. 2002. Respiratory syncytial virus infections in children. Semin. Respir. Infect. 17:15-20.
63. Tripp, R. A., A. Barskey, L. Goss, and L. J. Anderson. 2002. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J. Neuroimmunol. 129:141-153.
64. Tripp, R. A., L Jones, and L. J. Anderson. 2000. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J. Virol. 74:6227-6229.
65. Tripp, R. A., L. P. Jones, L M. Haynes, H. Zheng, P. M. Murphy, and L. J. Anderson. 2001. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2:732-738.
66. Tripp, R. A., D. Moore, and L. J. Anderson. 2000. TH(1)- and TH(2)-type cytokine expression by activated T lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus. Cytokine 12:801-807.
67. Tripp, R. A., D. Moore, L Jones, W. Sullender, J. Winter, and L. J. Anderson. 1999. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J. Virol. 73:7099-7107.
68. Tripp, R. A., D. Moore, J. Winter, and L. J. Anderson. 2000. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J. Virol. 74:1614-1622.
69. van Hagen, P. M., L. J. Hofland, A. M. ten Bokum, E. G. Lichtenauer-Kaligis, D. J. Kwekkeboom, D. Ferone, and S. W. Lamberts. 1999. Neuropeptides and their receptors in the immune system. Ann. Med. 31(Suppl. 2):15-22.
70. Varga, S. M., and T. J. Braciale. 2002. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 295:203-207.
71. Varga, S. M., X. Wang, R. M. Welsh, and T. J. Braciale. 2001. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity 15:637-646.
72. Ward, S. G., and J. Westwick. 1998. Chemokines: understanding their role in T-lymphocyte biology. Biochem. J. 333:457-470.
73. Weibel, R. E., J. Stokes, Jr., M. B. Leagus, C. C. Mascoli, A. A. Tytell, A. F. Woodhour, P. P. Vella, and M. R. Hilleman. 1967. Respiratory virus vaccines. VII. Field evaluation of respiratory syncytial, parainfluenza 1, 2, 3, and Mycoplasma pneumoniae vaccines, 1965 to 1966. Am. Rev. Respir. Dis. 96:724-739.
74. Wong, M., and E. N. Fish. 1998. RANTES and MIP-1alpha activate stats in T cells. J. Biol. Chem. 273:309-314.
75. Wong, M. M., and E. N. Fish. 2003. Chemokines: attractive mediators of the immune response. Semin. Immunol. 15:5-14.
76. Ying, S., Q. Meng, L. T. Barata, and A. B. Kay. 2001. Macrophage inflammatory protein-1alpha and C-C chemokine receptor-1 in allergen-induced skin late-phase reactions: relationship to macrophages, neutrophils, basophils, eosinophils and T lymphocytes. Clin. Exp. Allergy 31:1724-1731.